Logo Medical Science Monitor Basic Research

Call: 1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Contact Us

Logo Medical Science Monitor Basic Research Logo Medical Science Monitor Basic Research Logo Medical Science Monitor Basic Research

01 October 2005

Morphine via nitric oxide modulates beta-amyloid metabolism: a novel protective mechanism for Alzheimer's disease.

Theodore Pak, Patrick Cadet, Kirk J Mantione, George B Stefano

Med Sci Monit 2005; 11(10): BR357-366 :: ID: 429256

Abstract

Background: The deposition of intracellular and extracellular beta-amyloidpeptide (Abeta) in the brain is a pathologic feature of Alzheimer's disease (AD), a prevalent neurodegenerativedisorder. However, the exact role of the Abeta peptide in causing AD's symptoms is unclear. Material/Methods:CRL-2266 SH-SY5Y human neuroblastoma cells (ATCC, USA) and HTB-11 human neuroblastoma cells (ATCC, USA)were cultured. Reverse transcription-polymerase chain reaction (RT-PCR) was performed to analyze theeffects of beta25-35, morphine, and SNAP treatments upon BACE-1 and BACE-2 mRNA expression semi-quantitativeRT-PCR. The production of NO in SH-SY5Y cells was detected using the Apollo 4000 Free Radical Analyzer(World Precision Instruments). Results: Untreated HTB-11 neuroblastoma cells constitutively express BACE-1and BACE-2 mRNA. Morphine down regulates the expression of BACE-1 and up regulates the expression ofBACE-2 in a naloxone antagonizable manner. When HTB-11 cells were treated with L-NAME, a cNOS inhibitor;the effects of morphine were blocked. SNAP (a NO donor) mimicked the effect of morphine. In SH-SY5Y cells,Abeta treated cells show a dose-dependent decrease in NO release, demonstrating that Ab is dose-dependentlyinhibiting the release of constitutive NO. Conclusions: Ab and morphine/NO each inhibit the productionof the other. This suggests that a deficiency of basal NO or endogenous morphine may trigger drasticallyreduced levels of basal NO. The outcome is chronic vasoconstriction and brain hypoperfusion and eventualneuronal death. This novel theorized mechanism for AD supports an increasingly-accepted vascular pathologicalhypothesis for the disease.

Keywords: Aspartic Acid Endopeptidases - genetics, Amyloid beta-Peptides - metabolism, Amyloid Precursor Protein Secretases, Alzheimer Disease - prevention & control, Endopeptidases - genetics, Gene Expression Regulation, Enzymologic - physiology, Morphine - pharmacology, Nitric Oxide - physiology, RNA, Messenger - genetics, Reverse Transcriptase Polymerase Chain Reaction

Comments

Most Viewed Current Articles

31 Dec 1969 : Original article  

Outcome of 24 Weeks of Combined Schroth and Pilates Exercises on Cobb Angle, Angle of Trunk Rotation, Chest...

DOI :10.12659/MSMBR.920449

Med Sci Monit Basic Res 2020; 26:e920449

31 Dec 1969 : Original article  

Analysis of Psychological and Sleep Status and Exercise Rehabilitation of Front-Line Clinical Staff in the ...

DOI :10.12659/MSMBR.924085

Med Sci Monit Basic Res 2020; 26:e924085

31 Dec 1969 : Review article  

A Southeast Asian Perspective on the COVID-19 Pandemic: Hemoglobin E (HbE)-Trait Confers Resistance Against...

DOI :10.12659/MSMBR.929207

Med Sci Monit Basic Res 2021; 27:e929207

31 Dec 1969 : Clinical Research  

Effects of Cognitive Task Training on Dynamic Balance and Gait of Patients with Stroke: A Preliminary Rando...

DOI :10.12659/MSMBR.925264

Med Sci Monit Basic Res 2020; 26:e925264

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor Basic Research eISSN: 2325-4416
Medical Science Monitor Basic Research eISSN: 2325-4416